Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in New York, NY
NPI: 1033196506Primary Practice Location
International Multiple Sclerosis Management Practice, PC
521 W 57th St, New York, NY
Primary Employer
International Multiple Sclerosis Management Practice, PC
imsmp.org
HQ Phone
Get M.D. Saud's Phone Numberphone_androidMobile
Get M.D. Saud's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
University of Nairobi College of Health Sciences
Medical School
Until 1979
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator.
Authors: Molitor, Tyler P, Hayashi, Genki, Lin, Mei-Yao, Dunn, Carissa J, Peterson, Nathan G, Poston, Robert G, Kurnellas, Michael P, Traver, David A, Patel, Seona, Akgungor, Zeynep, Leonardi, Virginia, Lewis, Colizel, Segales, Joshua S, Bennett, Dylan S, Truong, Anh P, Dani, Manjari, Naphade, Swati, Wong, Jamie K, McDermott, Annie E, Kovalev, Sarah M, Ciaccio, Gillian L, Sadiq, Saud A, Pei, Zhonghua, Wood, Stephen, Rassoulpour, Arash
Journal: Proc Natl Acad Sci U S A
Publication Date: 2025-03-24
Safety of long-term intrathecal methotrexate in progressive forms of MS.
Authors: Stark, James W, Josephs, Lena, Dulak, Deirdre, Clague, Madison, Sadiq, Saud A
Journal: Ther Adv Neurol Disord
Publication Date: 2019-12-03
Lead Sponsor: Tisch Multiple Sclerosis Research Center of New York
Intervention / Treatment: BIOLOGICAL: Intrathecal MSC-NP injection, OTHER: Intrathecal saline injection
Lead Sponsor: Tisch Multiple Sclerosis Research Center of New York
Intervention / Treatment: DRUG: Intrathecal MSC-NP injection
